Hydroxyurea
- 1 August 1970
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 102 (2) , 144-150
- https://doi.org/10.1001/archderm.1970.04000080016003
Abstract
In a double-blind study, nine of ten cases of severe psoriasis demonstrated clinical and histopathologic response to hydroxyurea. No toxic reactions were noted. The drug may be less toxic than methotrexate and is efficacious in the management of psoriasis. A double-blind comparison of hydroxyurea and methotrexate is indicated to determine relative efficacy and toxicity.Keywords
This publication has 13 references indexed in Scilit:
- Hydroxyurea in PsoriasisPublished by Jaypee Brothers Medical Publishing ,2016
- Parenteral vs. Oral Folic Acid AntagonistsArchives of Dermatology, 1964
- Methotrexate-Induced Hepatic Injury in an AdultArchives of internal medicine (1960), 1964
- The Use of Folic Acid Antagonists and Steroids in Treatment of PsoriasisSouthern Medical Journal, 1963
- A Study of the Folic Acid Antagonists in the Treatment of Psoriasis (Aminopterin vs. Methotrexate vs. Aminopterin and a Corticosteroid)Dermatology, 1963
- Methotrexate vs. Aminopterin for PsoriasisArchives of Dermatology, 1961
- Further Observations on Aminopterin for Psoriasis11From the Division of Dermatology, Department of Medicine, University of California School of Medicine, San Francisco, California.Journal of Investigative Dermatology, 1959
- Treatment of Psoriasis with Folic Acid AntagonistsArchives of Dermatology, 1958
- Aminopterin for PsoriasisArchives of Dermatology, 1955
- EFFECT OF "AMINOPTERIN" ON EPITHELIAL TISSUESArchives of Dermatology, 1951